This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Huang, W.
Right arrow Articles by Eklund, E. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Huang, W.
Right arrow Articles by Eklund, E. A.

Next Article 

Molecular and Cellular Biology, September 2006, p. 6311-6332, Vol. 26, No. 17
0270-7306/06/$08.00+0     doi:10.1128/MCB.00036-06
Copyright © 2006, American Society for Microbiology. All Rights Reserved.

Leukemia-Associated, Constitutively Active Mutants of SHP2 Protein Tyrosine Phosphatase Inhibit NF1 Transcriptional Activation by the Interferon Consensus Sequence Binding Protein

Weiqi Huang,1,2 Gurveen Saberwal,1,2 Elizabeth Horvath,1 Chunliu Zhu,1 Stephan Lindsey,1 and Elizabeth A. Eklund1,2*

The Feinberg School of Medicine and The Robert H. Lurie Comprehensive Cancer Center, Northwestern University, Chicago, Illinois,1 Jesse Brown Veterans Health Administration Medical Center, Lakeside Division, Chicago, Illinois2

Received 7 January 2006/ Returned for modification 6 March 2006/ Accepted 15 June 2006

Deficiency in either the interferon consensus sequence binding protein (ICSBP) or neurofibromin 1 (Nf1) increases the proliferative response of myeloid progenitor cell to hematopoietic cytokines. Consistent with this, we previously demonstrated that ICSBP activates transcription of the gene encoding Nf1 (the NF1 gene). In the studies presented here, we determine that ICSBP tyrosine phosphorylation is necessary for the activation of NF1 transcription. Since ICSBP is tyrosine phosphorylated in response to hematopoietic cytokines, these studies identify a novel pathway by which cytokine-induced posttranslational modification of ICSBP results in NF1 transcription. Nf1 subsequently inactivates cytokine-activated Ras, thereby creating a negative feedback mechanism for cytokine-induced proliferation. In these studies, we also determine that ICSBP is a substrate for SHP2 protein tyrosine phosphatase (SHP2-PTP). We find that wild-type SHP2-PTP dephosphorylates ICSBP only in undifferentiated myeloid cells. In contrast, a leukemia-associated, constitutively activated mutant form of SHP2-PTP dephosphorylates ICSBP in both myeloid progenitors and differentiating myeloid cells. Activated SHP2-PTP mutants thereby inhibit ICSBP-dependent NF1 transcription, impairing this negative feedback mechanism on cytokine-activated Ras. Therefore, these studies suggest that leukemia-associated ICSBP deficiency cooperates with leukemia-associated activating mutants of SHP2-PTP to contribute to the proliferative phenotype in myeloid malignancies.


* Corresponding author. Mailing address: Feinberg School of Medicine, 710 North Fairbanks Court, Olson Pavilion Room 8524, Chicago, IL 60611. Phone: (312) 503-4625. Fax: (312) 908-5717. E-mail: e-eklund{at}northwestern.edu.


Molecular and Cellular Biology, September 2006, p. 6311-6332, Vol. 26, No. 17
0270-7306/06/$08.00+0     doi:10.1128/MCB.00036-06
Copyright © 2006, American Society for Microbiology. All Rights Reserved.




This article has been cited by other articles:

  • Zhou, J. X., Lee, C. H., Qi, C. F., Wang, H., Naghashfar, Z., Abbasi, S., Morse, H. C. III (2009). IFN Regulatory Factor 8 Regulates MDM2 in Germinal Center B Cells. J. Immunol. 183: 3188-3194 [Abstract] [Full Text]  
  • Koenigsmann, J., Rudolph, C., Sander, S., Kershaw, O., Gruber, A. D., Bullinger, L., Schlegelberger, B., Carstanjen, D. (2009). Nf1 haploinsufficiency and Icsbp deficiency synergize in the development of leukemias. Blood 113: 4690-4701 [Abstract] [Full Text]  
  • Yang, D., Wang, S., Brooks, C., Dong, Z., Schoenlein, P. V., Kumar, V., Ouyang, X., Xiong, H., Lahat, G., Hayes-Jordan, A., Lazar, A., Pollock, R., Lev, D., Liu, K. (2009). IFN Regulatory Factor 8 Sensitizes Soft Tissue Sarcoma Cells to Death Receptor-Initiated Apoptosis via Repression of FLICE-like Protein Expression. Cancer Res. 69: 1080-1088 [Abstract] [Full Text]  
  • Wang, H., Lindsey, S., Konieczna, I., Bei, L., Horvath, E., Huang, W., Saberwal, G., Eklund, E. A. (2009). Constitutively Active SHP2 Cooperates with HoxA10 Overexpression to Induce Acute Myeloid Leukemia. J. Biol. Chem. 284: 2549-2567 [Abstract] [Full Text]  
  • Huang, W., Zhu, C., Wang, H., Horvath, E., Eklund, E. A. (2008). The Interferon Consensus Sequence-binding Protein (ICSBP/IRF8) Represses PTPN13 Gene Transcription in Differentiating Myeloid Cells. J. Biol. Chem. 283: 7921-7935 [Abstract] [Full Text]  
  • Zhu, C., Lindsey, S., Konieczna, I., Eklund, E. A. (2008). Constitutive activation of SHP2 protein tyrosine phosphatase inhibits ICSBP-induced transcription of the gene encoding gp91PHOX during myeloid differentiation. J. Leukoc. Biol. 83: 680-691 [Abstract] [Full Text]  
  • Ozato, K., Tailor, P., Kubota, T. (2007). The Interferon Regulatory Factor Family in Host Defense: Mechanism of Action. J. Biol. Chem. 282: 20065-20069 [Abstract] [Full Text]  
  • Huang, W., Horvath, E., Eklund, E. A. (2007). PU.1, Interferon Regulatory Factor (IRF) 2, and the Interferon Consensus Sequence-binding Protein (ICSBP/IRF8) Cooperate to Activate NF1 Transcription in Differentiating Myeloid Cells. J. Biol. Chem. 282: 6629-6643 [Abstract] [Full Text]  
  • Lindsey, S., Huang, W., Wang, H., Horvath, E., Zhu, C., Eklund, E. A. (2007). Activation of SHP2 Protein-tyrosine Phosphatase Increases HoxA10-induced Repression of the Genes Encoding gp91PHOX and p67PHOX. J. Biol. Chem. 282: 2237-2249 [Abstract] [Full Text]  
  • Middleton, M. K., Zukas, A. M., Rubinstein, T., Jacob, M., Zhu, P., Zhao, L., Blair, I., Pure, E. (2006). Identification of 12/15-lipoxygenase as a suppressor of myeloproliferative disease. JEM 203: 2529-2540 [Abstract] [Full Text]